Skip to main content

Table 1 Patient and disease characteristics at baseline

From: Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Patient characteristics Patients (n = 33)
  No. %
Age 59 years
Median (range) (35–68)
PS (ECOG)   
Median (range) 0 (0–1)
Menopausal status   
   Pre 6 18.2
   Post 27 81.8
Stage   
   Locally advanced 7 21.2
   Metastatic:   
1 site 9* 27.3
≥ 1 site 17 51.5
Site   
   Breast 12 36.4
   Bone 20 60.6
   Liver 12* 36.4
   Lung 8 24.2
   Lymph nodes 4 12.1
Receptor status   
   ER+ 22 66.7
   ER- 8 24.2
   Unknown 3 9.1
Prior therapy   
   None 16 48.5
   Adjuvant hormonal therapy 4 12.1
   Adjuvant chemotherapy 7 21.2
   Chemo- and hormone adjuvant therapy 4 12.1
   Hormone therapy for advanced disease 6 18.2
  1. *One instrumentally detected hepatic lesion was histologically diagnosed a posteriori as an angioma